April 20, 2014 2:10 AM ET

Pharmaceuticals

Company Overview of Pharnext SAS

Executive Profile

Daniel E. Cohen M.D., Ph.D.

Co-founder and Chairman, Pharnext SAS
AgeTotal Calculated CompensationThis person is connected to 4 Board Members in 4 different organizations across 4 different industries.

See Board Relationships
60--

Background

Dr. Daniel E. Cohen, MD, PhD serves as Chief Scientific Officer and Directeur Général Délégué of Serono Genetics Institute S.A. Dr. Cohen is the Founder of CNS Inc. He is a Co-Founder of Millennium Pharmaceuticals, Inc., and Pharnext SAS. Dr. Cohen is Founder of modern genetics, genomics and pharmacogenomics. He joined Serono Genetics Institute S.A. in 1996 as Chief Genomics Officer and Directeur Général. He served as the Chief Executive Officer of CNS Inc. from 1989 ...

Corporate Headquarters

Pépinière Santé Cochin
Paris, Ile-de-France 75014

France

Phone: 33 1 55 42 62 00
Fax: 33 1 55 42 62 01

Board Members Memberships

Chief Scientific Officer, Director and Directeur Général Délégué
Co-founder and Chairman
1982-N/A
Founder

Education

PhD
Université Denis Diderot - Paris VII
MD
Université Denis Diderot - Paris VII
Honorary Doctorate
Shanghai University

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Pharnext SAS, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.